Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | BTN3A1 | O00481 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | MVD | P53602 | 1/20 | 0.33 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.33 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26383509 | 0.98 | PPARD (0.46) | PPARDTSHRBTN3A1TP53TDP1 | |
| SCHEMBL627986 | 0.88 | PPARD (0.54) | PPARDTSHRBTN3A1TP53TDP1 | |
| Ammonia Solution, Strong SCHEMBL628386 | 0.85 | PPARD (0.52) | PPARDTSHRBTN3A1TP53TDP1 | |
| SCHEMBL887550 | 0.85 | — | — | |
| SCHEMBL8078110 | 0.84 | BTN3A1 (0.50) | PPARDTSHRBTN3A1TDP1MVD | |
| Diethyl Hydrogen Phosphate SCHEMBL22471870 | 0.83 | TSHR (0.46) | PPARDTSHRTP53TDP1PLA2G2A | |
| Fluoride SCHEMBL28490002 | 0.83 | TSHR (0.46) | PPARDTSHRTP53TDP1PLA2G2A | |
| Ammonia Solution, Strong SCHEMBL26929057 | 0.83 | — | — | |
| SCHEMBL13254631 | 0.83 | FDPS (0.39) | BTN3A1TDP1P2RY2P2RY4 | |
| SCHEMBL28480515 | 0.82 | BTN3A1 (0.48) | PPARDTSHRBTN3A1TDP1MVD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009040087-A2 | THERAPEUTIC USE OF PEPTIDE YGLF AND COMBINATION WITH KVLPVPQ | MONDOBIOTECH LABORATORIES AG (LI) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009033794-A2 | USE OF ENDOTHELIN-1, OPTIONALLY IN COMBINATION WITH OBESTATIN, AS A THERAPEUTIC AGENT | MONDOBIOTECH LABORATORIES AG (LI) | 2009-03-19 | — | — | WO | disclosed |
| WO-2009033793-A2 | PENTAGASTRIN AS A THERAPEUTIC AGENT | MONDOBIOTECH LABORATORIES AG (LI) | 2009-03-19 | — | — | WO | disclosed |